Skip to search formSkip to main contentSkip to account menu

Niaspan

National Institutes of Health

Related topics

Related topics

3 relations
24 HR Niacin 500 MG Extended Release Oral Tablet [Niaspan]NiacinVitamin B3 Assay

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Flushing with Niaspan in the NAUTILUS trial, a 15-week evaluation of Niaspan at doses up to 2000 mg/day in 566 patients with dyslipidemia and low HDL-cholesterol managed in the usual care setting
2011
2011
Dose-related effect of Niaspan (500–3000 mg/day) on lipid parameters in a 25-week, double-blind, randomized trial in 131 patients with hyperlipidemia
2010
2010
COST EFFECTIVENESS OF IMPLANTABLE LOOP RECORDER SYSTEM (REVEAL DX®) FROMTHE SPANISH NHS PERSPECTIVE
  • 2010
  • Corpus ID: 119070702
COST-EFFECTIVENESS OF NIASPAN®VERSUS ZETIA® AS ADD-ONTREATMENTTO STATINTHERAPY IN HIGH-RISK PATIENTS Sorensen SV,Webb SF, Burge… 
2009
2009
LIPID CASE # 203 PCOS and TG / HDL Axis Disorder
  • 2009
  • Corpus ID: 34660532
TC = 203, TG = 379, HDL-C = 37, LDL-C = 90 and fasting insulin 26. NMR LipoProfile (lipoprotein concentrations) LDL-P = 1820… 
2009
2009
Niaspan Tops Zetia In New Setback For Merck Drug
2006
2006
Frauenärztliche Aspekte des metabolischen Syndroms
ZusammenfassungDas metabolische Syndrom basiert auf Suszeptibilitätsgenen und entwickelt sich durch Umwelteinflüsse. Seine… 
2004
2004
Niaspan successfully completes European mutual recognition procedure
  • 2004
  • Corpus ID: 195128986
2000
2000
The antilipidemic effects of plain and extended-release niacin.
The extensive antihyperlipidemic effects of niacin are well known. Cardiac doses of niacin are effective in lowering low density… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)